633 NM · RED
Collagen + firmness
Penetrates 1–2mm into the dermis. Stimulates fibroblasts. Best for fine lines, elasticity, and overall plumpness.
PXL Mask is built around a simple shift: stop treating the face like one surface, and start treating it like a coordinate system. Three pieces make it possible.
The PXL app uses Apple's TrueDepth and LiDAR sensors to project tens of thousands of infrared points across your face — building a millimeter-accurate mesh in under four seconds.
Hold up your phone. We'll map 468 facial landmarks using your front camera — running entirely on-device. No video, photos, or scan data leaves your phone.
This is a 2D preview. The full clinical scan — TrueDepth-accurate to half a millimeter, the one your treatment plan is built from — happens in the iOS app.
Estimates based on your 2D landmark map. The iOS app refines this with TrueDepth depth data and skin-condition tagging.
Want the full clinical scan and a treatment plan dialed to your skin? The iOS app uses TrueDepth + LiDAR for sub-millimeter mapping.
Inside the mask, 1,024 individually-addressable RGB+IR LEDs sit on a curved silicone substrate. Software treats them as a 2D pixel array — addressable per-zone, per-wavelength, per-phase.
Each wavelength addresses a different layer of skin biology. PXL fires them simultaneously across your map — not in single-color sessions, the way a conventional mask would.
Penetrates 1–2mm into the dermis. Stimulates fibroblasts. Best for fine lines, elasticity, and overall plumpness.
Activates porphyrins in C. acnes bacteria. Reduces active breakouts and post-inflammatory marks. Targeted at T-zone and jaw.
Calms erythema, modulates melanin synthesis. Evens skin tone over 6–8 weeks. Targeted at cheeks and around the nose.
Penetrates up to 5mm. Boosts mitochondrial activity, improves circulation, supports tissue repair. Used in periorbital and deeper zones.
Low-level light therapy at 633nm and 850nm has been studied in over 200 peer-reviewed dermatology trials. PXL Mask's wavelengths and irradiance are within the established clinical envelope — what's new is the spatial control.